Cargando…
Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events
INTRODUCTION: The gut microbiota is implicated in the occurrence and severity of immune-related adverse events (irAEs), but the role it plays as well as its causal relationship with irAEs has yet to be established. METHODS: From May 2020 to August 2021, 93 fecal samples were prospectively collected...
Autores principales: | Liu, Xinyu, Tang, Hao, Zhou, Qingyang, Zeng, Yanlin, Lu, Bo, Chen, Dan, Li, Yue, Qian, Jiaming, Chen, Minjiang, Zhao, Jing, Xu, Yan, Wang, Mengzhao, Tan, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986626/ https://www.ncbi.nlm.nih.gov/pubmed/36891304 http://dx.doi.org/10.3389/fimmu.2023.1109281 |
Ejemplares similares
-
Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events
por: Zeng, Yanlin, et al.
Publicado: (2023) -
Gut microbiota shed new light on the management of immune‐related adverse events
por: Tan, Bei, et al.
Publicado: (2022) -
Experiencing social exclusion changes gut microbiota composition
por: Kim, Chong-Su, et al.
Publicado: (2022) -
Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer Patient
por: Chen, Minjiang, et al.
Publicado: (2021) -
Gut Microbiota Composition Is Related to AD Pathology
por: Verhaar, Barbara J. H., et al.
Publicado: (2022)